Skip to content
‹ Back to IndustriesSciences

Just Thinking… About Bridging the Gap Between Classrooms and Real-World Scientific Research

A discussion between Kevin Dougherty and Jason Osborne, Chief Business Officer at syGlass, explores how curiosity-led learning can bridge K-12 education and real-world scientific research. The conversation emphasizes engineering learning systems that use emerging technologies like AR and VR to prepare students for modern workforce demands while enabling them to contribute to actual scientific projects.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale · · Jason OsborneJust ThinkingKevin DoughertyScientific Research
Share

Key takeaways

01

As advancements in technology reshape how we learn, innovate, and engage with scientific research, how can we cultivate a scientific mindset in education and beyond?

02

Today’s discussion highlights a growing emphasis on curiosity-led learning as a catalyst for systemic change in education.

03

Curiosity plays a crucial role in learner engagement, with research showing that…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

As advancements in technology reshape how we learn, innovate, and engage with scientific research, how can we cultivate a scientific mindset in education and beyond? Today’s discussion highlights a growing emphasis on curiosity-led learning as a catalyst for systemic change in education. Curiosity plays a crucial role in learner engagement, with research showing that it not only prepares the brain for learning but also significantly impacts academic achievement. So, how can we make curiosity a foundational element in classrooms and organizations?

In this episode of Just Thinking, host Kevin Dougherty is joined by Jason Osborne, the Chief Business Officer at syGlass and a multi-faceted explorer, inventor, and advocate for citizen science. Together, they explore the power of curiosity to inspire breakthroughs and discuss how we can better engineer learning systems to ignite curiosity in students, educators, and professionals alike.

Key Questions Addressed:

  • How can curiosity reshape education and scientific discovery?
  • What role does technology like VR and AR play in modern education?
  • How do we bridge the gap between K-12 education and real-world scientific research?

Key Takeaways:

  • Curiosity as a Catalyst: Osborne shares his journey from a small-town farm to becoming an inventor and White House Champion of Change.
  • Learning Engineering: Insights into how Osborne implemented systems to “engineer learning,” enabling students to contribute to real-world scientific research, including projects on neuroscience and paleontology.
  • Bridging Education and Technology: Discussion on using emerging tools like AR/VR to create immersive learning experiences and preparing students for the evolving demands of the workforce.

Jason Osborne is the Chief Business Officer at syGlass, with a career spanning biomedical science, aerospace, and education innovation. A White House Champion of Change and advocate for citizen science, Osborne has collaborated with institutions like the Howard Hughes Medical Institute, National Geographic, and the Smithsonian. His discoveries in paleontology have been chronicled by platforms like Discovery Channel and NPR, making him a pivotal figure in connecting education with cutting-edge science.

Article written by MarketScale.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

M
MarketScale

Host, Just Thinking

Kevin Dougherty is the host of the 'Just Thinking' podcast. He explores topics around technology, education, and curiosity-led learning. He engages with experts to discuss innovations in these fields.

JO
Jason Osborne

Chief Business Officer

syGlass

Jason Osborne is the Chief Business Officer at syGlass and an advocate for citizen science. He is known for his work in implementing systems to engineer learning and preparing students to contribute to research projects in neuroscience and paleontology.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512